PW MEDTECH (01358) purchased 2.4149 million Hong Kong dollars to repurchase 2.044 million shares on May 11th.
PwC and Shun (01358) announced that on May 11, 2026, the company spent 2.4119 million Hong Kong dollars to repurchase 2.044 million shares at a repurchase price of 1.18 Hong Kong dollars per share.
PW MEDTECH (01358) announced that on May 11, 2026, the company spent HK$2.4119 million to repurchase 2.044 million shares at a price of HK$1.18 per share.
Related Articles
On May 11, LIANLIAN (02598) spent HK$1.3626 million to repurchase 229,500 shares.
JST GROUP (06687) spent 1.9975 million Hong Kong dollars to repurchase 12.88 thousand shares on May 11th.
Shenzhen Sunxing Light Alloys Materials (603978.SH): "Construction and completion of the third phase of the project to produce 15,000 tons of lithium hexafluorophosphate per year."
On May 11, LIANLIAN (02598) spent HK$1.3626 million to repurchase 229,500 shares.
JST GROUP (06687) spent 1.9975 million Hong Kong dollars to repurchase 12.88 thousand shares on May 11th.
Shenzhen Sunxing Light Alloys Materials (603978.SH): "Construction and completion of the third phase of the project to produce 15,000 tons of lithium hexafluorophosphate per year."
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
